Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALB vs GSK✓SelectedUSD · GSKALB vs GSK performance historyLatest closeAs of-3.37%11/19
Stock and ETF performance explorer

ALB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.0%
GSK return
+97.7%
Excess return
-84.7%
Maximum drawdown
-83.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.4%-1.6%-1.8%-2.8%
7D-12.6%-4.7%-7.8%-11.0%
30D-13.4%-4.7%-8.7%-12.0%
3M-38.0%-8.8%-29.3%-36.1%
6M-50.6%-4.6%-46.0%-50.1%
YTD-40.9%+1.0%-41.9%-42.0%
1Y-33.3%+6.9%-40.1%-35.9%
3Y-31.8%+52.5%-84.3%-45.3%
5Y-68.7%+40.3%-109.0%-74.6%
All+13.0%+97.7%-84.7%-19.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling